Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion

Chest

Volumn 121, Issue 3 SUPPL., 2002, Pages 821-824

  Shoji, Tsuyoshi ^a   Tanaka, Fumihiro ^a   Yanagihara, Kazuhiro ^a   Inui, Kenji ^a   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Implantable access system; Intrapleural chemotherapy; Malignant pleural effusion

Indexed keywords

CISPLATIN; FLUOROURACIL; FLUOROURACIL DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRAIN; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMATOTHORAX; HUMAN; IMPLANTABLE PORT SYSTEM; LUNG CANCER; MALE; MESOTHELIOMA; OUTPATIENT; PHASE 2 CLINICAL TRIAL; PLEURA CANCER; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; SAFETY; THORACOSCOPY; TREATMENT OUTCOME;

EID: 0036202317     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3.821     Document Type: Article

References (17)

1. Survival and talc pleurodesis in metastatic pleural carcinoma, revisited: Report of 125 cases
2. Pleural sclerosis for the treatment of pneumothorax and pleural effusion
3. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions
4. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter
5. Totally implantable system for peritoneal access
6. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer
7. Use of an implantable catheter system for intraperitoneal chemotherapy in ovarian cancer
8. Implantable access system for prolonged intrapleural immunotherapy
9. ASCO special article: Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer
10. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
11. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer: West Japan Study Group for Lung Cancer Surgery
12. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer: A randomized trial
13. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions: LCSG Trial 861
14. Subcutaneous access ports with fenestrated catheters for improved management of recurrent pleural effusions
15. A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer
16. Treatment of malignant pleural effusions with doxorubicin hydrochloride-containing poly(L-lactic acid) microspheres
17. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion